Peter Pecháň

Therapeutic Efficiency and Safety of a Second-Generation Replication-Conditional HSV1 Vector for Brain Tumor Gene Therapy

C M Kramm, Maureen Chase, Ulrich Herrlinger et al. · Human Gene Therapy · 1997 · 169 citations

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Alice K. Jacobs, Michael Dubrovin, Timothy Akhurst et al. · PubMed · 2001 · 155 citations

Viral Replication, Gene Therapy Strategies, Engineering +22

HSV/AAV Hybrid Amplicon Vectors Extend Transgene Expression in Human Glioma Cells

Karen M. Johnston, David Jacoby, Peter Pecháň et al. · Human Gene Therapy · 1997 · 131 citations

Viral Replication, Immunology, Molecular Biology +20

Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization

Peter Pecháň, Hillard Rubin, Michael Lukason et al. · Gene Therapy · 2008 · 106 citations

Ocular Disease, Angiogenesis, Ophthalmology +7

Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule

Michael Lukason, Elizabeth DuFresne, Hillard Rubin et al. · Molecular Therapy · 2010 · 82 citations · Full text

Ocular Disease, Retinal Neovascularization, Immunology +17